| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| Elacestrant 二盐酸盐 | Elacestrant hydrochloride | 1349723-93-8 | C30H40Cl2N2O2 |
| Egenine; (6R,8S)-6,8-二氢-6-[(5S)-5,6,7,8-四氢-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基]呋喃并[3,4-e]-1,3-苯并二氧杂环戊烯-8-醇 | (+)-egenine | 6883-44-9 | C20H19NO6 |
| Eg5抑制剂VII | 6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-quinolin-2-one | 912953-25-4 | C16H12F3NO |
| Eg5抑制剂IV,VS-83 | Eg5 Inhibitor IV, VS-83 | 909250-29-9 | C14H11FN2OS |
| EZH2甲基转移酶抑制剂(GSK126) | GSK-126 | 1346574-57-9 | C31H38N6O2 |
| EZATIOSTAT游离的 | γ-glutamyl-S-(benzyl)cysteinyl-(R)-(-)-phenylglycine diethyl ester | 168682-53-9 | C27H35N3O6S |
| EVACETRAPIB中间体 | methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetra-hydro-1H-benzo[b]azepine-1-carboxylate | 1259393-27-5 | C14H17NO3 |
| ETHYLONE盐酸盐 | bk-MDEA (hydrochloride) | 1454266-19-3 | C12H16ClNO3 |
| ETHYL4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-1-THIO-Β-D-GLUCOPYRANOSIDE乙基4,6-O-亚苄基-2-脱氧-2-邻苯二甲酰亚氨基-1-硫代-Β-D-吡喃葡萄糖苷 | ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside | 99409-33-3 | C23H23NO6S |
| ETHYL3-O-(2-NAPHTHYL)METHYL-4,6-O-BENZYLIDENE-1-THIO-Β-D-GLUCOPYRANOSIDE乙基3-O-(2-萘基)甲基-4,6-O-亚苄基-1-硫代-Β-D-吡喃葡萄糖苷 | ethyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside | 352008-09-4 | C26H28O5S |
| ETHYL2,4,6-TRI-O-ACETYL-3-O-(2-NAPHTHYL)METHYL-1-THIO-Β-D-GLUCOPYRANOSIDE乙基2,4,6-三-O-乙酰基-3-O-(2-萘基)甲基-1-硫代-Β-D-吡喃葡萄糖苷 | ethyl 2,4,6-tri-O-acetyl-3-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside | 352008-02-7 | C25H30O8S |
| ETHYL 5-硝基-2-吡啶乙基甲苯 | ethyl 5-nitropicolinate | 30563-98-5 | C8H8N2O4 |
| ESTRATETRAENONE甲酯 | Equilin 3-methyl ether | 6030-83-7 | C19H22O2 |
| ERRΒ/Γ激动剂(GSK-4716) | (E)-N'-(4-(diethylamino)benzylidene)-4-hydroxybenzohydrazide | 95167-41-2 | C18H21N3O2 |
| ERK抑制剂II,阴性对照 | ERK Inhibitor II, Negative Control | 1177970-73-8 | C18H12N6O |
| EP杂质R2,3-二氢三尖杉宁碱 | N-debenzoyl-N-((S)-2-methylbutanoyl)paclitaxel | 158948-96-0 | C45H55NO14 |
| EP杂质Q | 4,10beta-bis(acetyloxy)-13alpha-[[(2R,3S)-3-[[(3E)-hex-3-enoyl]amino]-2-hydroxy-3-phenylpropanoyl]oxy]-1,7beta-dihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate | 2243233-98-7 | C46H55NO14 |
| EPZ005687抑制剂 | EPZ005687 | 1396772-26-1 | C32H37N5O3 |
| EPSILON-(GAMMA-L-谷氨酰)-L-赖氨酸 | epsilon-(gamma-glutamyl)lysine | 17105-15-6 | C11H21N3O5 |
| EPA乙酯 | Methyl (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoate | 28061-46-3 | C23H34O2 |
| EPA乙酯 | eicosapentaenoic acid ethyl ester | 86227-47-6 | C22H34O2 |
| ENT-甲磺酸帕珠沙星 | ent-Pazufloxacin Mesylate | 677004-96-5 | C17H19FN2O7S |
| ENT-他达拉非 | (+/-) cis-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione | 629652-72-8 | C22H19N3O4 |
| ENS-163磷酸盐 | ENS-163 phosphate | 117707-51-4 | C11H19N2O5PS |
| ENDOGLYCOSIDASEF2来源于脑膜炎脓毒性黄杆菌 | mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase | 37278-88-9 | —— |
| EMT抑制剂-1 | 4-((4-(3,4-dichlorophenyl)-1,2,5-thiadiazol-3-yl)oxy)butan-1-ol | 1638526-21-2 | C12H12Cl2N2O2S |
| EMPAGLIFLOZIN杂质104 | (5-chloro-2-iodophenyl)(2-fluorophenyl)methanone | 76049-49-5 | C13H7ClFIO |
| EMD638683 (形态 S); (alphaS)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 | N'-[(S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide | 1184940-46-2 | C18H18F2N2O4 |
| EMD638683 (形态 R); (alphaR)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 | N'-[(R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide | 1184940-47-3 | C18H18F2N2O4 |
| EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 | tepotinib | 1100598-32-0 | C29H28N6O2 |
| EMD 534085; N-[2-(二甲基氨基)乙基]-N'-[[(2R,4aS,5R,10bS)-3,4,4a,5,6,10b-六氢-5-苯基-9-(三氟甲基)-2H-吡喃并[3,2-c]喹啉-2-基]甲基]脲 | EMD 534085 | 858668-07-2 | C25H31F3N4O2 |
| ELA锁链素 | 4-(16-(S)-amino-16-carboxybutyl)-1-(11-(S)-amino-11-carboxypentyl)-3,5-bis-(20,20’-(S)-amino-20,20’-carboxypropyl)pyridinium | 11003-57-9 | C24H40N5O8 |
| EIPA盐酸盐 | ethylisopropyl amiloride hydrochloride | 1345839-28-2 | C11H18ClN7O*ClH |
| EGFR抑制剂 | EGFR Inhibitor | 879127-07-8 | C21H18F3N5O |
| EGFR-IN-9(化合物8) | N-{3-[4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]-pyrimidin-5-yl]phenyl}acrylamide | 1226549-39-8 | C29H24N4O3 |
| EED抑制剂(EEDINHIBITOR-1) | MAK683 | 1951408-58-4 | C20H17FN6O |
| EDTMP钾 | Tetrapotassium [({2-[bis(phosphonomethyl)amino]ethyl}azanediyl)bis(methylene)]bis(phosphonate) | 34274-30-1 | C6H16K4N2O12P4 |
| EDTA铁钾盐 | Potassium ferric ethylenediaminetetraacetate | 54959-35-2 | C10H12FeKN2O8 |
| EDTA钙盐 | Ethylenediaminetetraacetic acid dicalcium salt | 19709-85-4 | C10H12Ca2N2O8 |
| EDTA四铵 | Tetraammonium ethylenediaminetetraacetate | 22473-78-5 | C10H16N2O8.4H3N |
| EDTA三钾盐二水合物 | tripotassium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)azaniumyl]acetate;dihydrate | —— | C10H17K3N2O10 |
| EDDP高氯酸盐标准品 | (+/-)-2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium perchlorate | 31161-17-8 | C20H24N*ClO4 |
| EBP氯代物杂质 | 5'-Chloro eltrombopag | 376592-56-2 | C25H21ClN4O4 |
| EAM-1试剂 | [2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl]trimethylammonium | 287970-46-1 | C11H16N5O3 |
| EA671;;二噻吩[3,2-E:2,3-G]-2,1,3-苯并噻二唑 | dithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole | 1256138-50-7 | C10H4N2S3 |
| E3330抑制剂 | E 3330 | 136164-66-4 | C21H30O6 |
| E-阿魏酸二十二烷基酯 | Docosylferulate | 101927-24-6 | C32H54O4 |
| E-邻甲基苯乙酮肟 | E-ortho-methylacetophenone oxime | 68251-94-5 | C11H15Br |
| E-甲基-3-(5-甲酰基-2-呋喃基)-(2-对甲氧基苯基)丙烯酸酯 | E-methyl-3-(5-formyl-2-furyl)-(2-p-methoxyphenyl) acrylate | 105199-78-8 | C16H14O5 |
| E-甲基-3-(2-呋喃基)-(2-甲基苯基)丙烯酸酯 | E-methyl-3-(2-furyl)-(2-m-methylphenyl) acrylate | 105199-76-6 | C15H14O3 |